Effects of adjustable gastric banding on altered gut neuropeptide levels in morbidly obese patients

Obesity Surgery

Volumn 11, Issue 6, 2001, Pages 735-739

  Weiss, H ^a   Labeck, B ^a   Klocker, J ^a   Nehoda, H ^a   Mittermair, R ^a   Aigner, F ^a   Gadenstatter M ^a   Schwelberger, H ^a   Wetscher, G ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Adjustable gastric banding; Bariatric surgery; Gastroesophageal reflux; Morbid obesity; Motilin; Neurotensin

Indexed keywords

MOTILIN; NEUROPEPTIDE; NEUROTENSIN;

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPHAGIA; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; ESOPHAGUS PH; FEMALE; FOLLOW UP; GASTRIC BANDING; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; MORBID OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROPLASTY; HUMANS; HYDROGEN-ION CONCENTRATION; LAPAROSCOPY; MALE; MANOMETRY; MIDDLE AGED; MOTILIN; NEUROTENSIN; OBESITY, MORBID;

EID: 0035663281     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/09608920160558687     Document Type: Article

References (22)

1. In man, only activity fronts that originate in the stomach correlate with motilin peaks
2. Gastroesophageal reflux disease is associated with enteric hormone abnormalities
3. Abnormal plasma gut hormones in pathologic duodenogastric reflux and their response to surgery
4. Alterations of gut neuropeptides in gastroesophageal reflux disease are resolved following antireflux surgery
5. Manometric studies of lower esophageal sphincter in extreme obesity
6. High prevalence of asymptomatic esophageal motility disorders among morbidly obese patients
7. Gastrointestinal motility in obesity
8. Relationship of overweight to hiatus hernia and reflux oesophagitis
9. Treatment of morbid obesity with laparoscopic adjustable gastric banding affects esophageal motility
10. A gastric band with adjustable inner diameter for obesity surgery
11. Results and complications following adjustable gastric banding in a series of 250 patients
12. Tailored antireflux surgery for gastroesophageal reflux disease: Effectiveness and risk of postoperative dysphagia
13. Respiratory symptoms in patients with gastroesophageal reflux disease following medical therapy and following antireflux surgery
14. Technique, indications, and clinical use of 24-hour esophageal pH monitoring
15. Plasma concentrations of regulatory peptides in obesity following modified sham feeding (MSF) and a liquid test meal
16. Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity
17. Reduced food intake after jejunoileal bypass: A possible association with prolonged gastric emptying and altered gut hormone patterns
18. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity
19. Hyperinsulinaemia impairs gastrointestinal motility and slows carbohydrate absorption